Technology Transfer / Available Technologies
For information on licensing any of these items, please email
Nathan S Kline Institute
Patent No.
Pub. Appl
Aging, Alzheimer's Disease & Dementia
Methods for the Identification of Compounds for the Treatment of Alzheimer’s Disease 6,838,592  
Methods for the Identification of Compounds for the Treatment of Neuronal Atrophy-Associated Dementia 7,090,987  
Methods for Screening to Identify Therapeutic Agents for Alzheimer's Disease and Use Thereof   20120136064
Methods and Compositions Relating to Cystatin C 7,790,673 WO2005059100
Neuropsychiatric Disorders
Treatment of Negative & Cognitive Symptoms of Schizophrenia with D-Serine


Assay for D-Serine Transport Antagonist for Use and for Treating Psychosis 6,361,957  
System and Method for Diagnosis & Treatment of Neuropsychiatric Disorders 8,076,075 20120114767
Research Tools
Transgenic Mice Comprising a Genomic Human Tau Transgene 7,161,060  
Tissue Embedding Matrix 8,257,942  
Methods and Compositions for Amplification & Detection of microRNAs 8,580,494 14/076513
Various monoclonal antibodies

BioLegend antibody products

Copyrighted Works Relating to Mental Health
Recovery from Schizophrenia: An International Perspective- A Report from the WHO Collaborative Project, the International Study of Schizophrenia Copyrighted work
Toolkit for Modifying Evidence-Based Practices to Increase Cultural Competence Copyrighted work
Institute for Basic Research
Patent No.
Pub. Appl
Aging, Alzheimer’s Disease, Neurodegenerative Diseases & Neuropsychiatric Disorders
Method for Differentiation of Alzheimer's Disease into Subgroups 7,256,003 20080070263
LMNA Gene and its Involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and Arteriosclerosis 8,034,557  
Neurotrophic Peptides 8,338,378 20110160141
NMDA Receptor Antagonists and Their Use in Inhibiting Abnormal Hyperphosphorylation of Microtubule Associated Protein Tau   20120157537
System and Method for Evaluating Blood-Neural Barrier Permeability 8,349,577  
Treatment of Central Nervous System Disorders Associated with Psychotic Behavior and Dementia with a Combination of Neuroleptic Drugs and Taurine, or Derivatives Thereof, to Prevent the Development of Tardive Dyskinesia 5,602,150  
Intranasal Insulin Prevents Anesthesia-Induced Cognitive Impairment 9,603,905  
Research Tools
Detection of Novel Carbohydrates Associated with Chronic Alcoholism


Systems, Devices, and Methods for Monitoring and Analyzing Research Animal Behavior Before, During, and After Brain Electrical Stimulation   20120143280
Rapid Antemorten Detection of Infectious Agents (infectious agents are prion proteins)   20100261195
Various monoclonal & polyclonal antibodies (amyloid- β peptide, tau proteins, cleavage product of α -secretase, ferritin, spectrin, PrP, etc.) BioLegend antibody products
Others available for licensing
Transgenic Mice Expressing Cervid, Ovine, and Human Prion Protein Genes Available for licensing
Expression & Purification of Recombinant Human Tau in Biologically Active Form Available for licensing
Human Brain tau441 Stably Transfected PC12 Cell Line Available for licensing
Copyrighted Works Relating to Mental Health
Asperger’s Disorder Behavior Inventory Copyrighted work
PDD Behavior Inventory Copyrighted work

Health Advocacy Program: An Activity-Based Curriculum for Adults with Developmental Disabilities

Copyrighted work
New York Psychiatric Institute
Patent No.
Pub. Appl
Columbia Suicide Severity Rating Scale (C-SSRS) Copyrighted work
Genetic Markers of True Low Birth Weight   20090087845

Top of page

NOTE: Copyrighted works are to be used with permission of the author only.


2000 Research Foundation for Mental Hygiene, Inc. All Rights Reserved.
Terms under which this service is provided to you. Read our privacy guidelines